Immutep Limited Class Action Lawsuit
Company: Immutep Limited
Ticker: (NASDAQ) IMMP
Class Action Period: March 24, 2025 - March 12, 2026
See If You Qualify For Monetary Reward
Join the Immutep Limited Class Action Lawsuit
CLASS ACTION PERIOD
March 24, 2025 - March 12, 2026
Allegations
According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating false and misleading statements and/or concealing material adverse facts concerning the efficacy and safety of its TACTI-004 Phase III clinical trial study. On March 13, 2026, Immutep issued a press release announcing that the Independent Data Monitoring (IDMC) for the TACTI-004 Phase III study recommended that the trial be discontinued following a planned interim futility analysis. Further, based on its review of the available safety and efficacy data, the IDMC recommended that the trial be discontinued for futility. Following this news, the price of Immutep’s ADRs declined dramatically. From a closing market price of $2.76 per share on March 12, 2026, Immutep’s stock price fell to $0.48 per share on March 13, 2026, a decline of about 83%.
Eligibility
To join the lawsuit, you must have experienced a loss on Immutep Limited shares purchased within the class period specified above.
Lead Plaintiff Deadline
If you suffered a loss in Immutep Limited during the relevant time frame, you have until July 6, 2026 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Frequently Asked Questions
- How do I join the lawsuit against Immutep Limited (NASDAQ: IMMP)?
Investors who purchased shares of Immutep Limited (NASDAQ: IMMP) during the class period (March 24, 2025 - March 12, 2026) can join by submitting their transaction details through this case page.
- Ensure your purchase falls within the class period
- Provide basic transaction and loss details
- Submit your information before the deadline
The lead plaintiff deadline for this case is July 6, 2026, so investors should act quickly to protect their rights.
- Who is eligible for the Immutep Limited lawsuit?
Anyone who bought shares of Immutep Limited (NASDAQ: IMMP) during March 24, 2025 - March 12, 2026 and suffered financial losses may qualify.
- What is the lead plaintiff deadline to join the Immutep Limited case?
The lead plaintiff deadline for the Immutep Limited lawsuit is July 6, 2026. Investors should act quickly to avoid missing this deadline.
- What is the class period for Immutep Limited?
The class period for Immutep Limited (NASDAQ: IMMP) is March 24, 2025 - March 12, 2026, during which investors may have been affected by alleged misconduct.
- Can I still join the Immutep Limited lawsuit if I sold my shares?
Yes. Investors who purchased Immutep Limited shares during March 24, 2025 - March 12, 2026 may still qualify, even if they sold their shares later.
- How much compensation can I receive from the Immutep Limited lawsuit?
Compensation depends on the total losses and the final settlement. Eligible investors in the Immutep Limited case may receive a portion of the recovery.
- Do I need to pay to participate in the Immutep Limited case?
No, most securities fraud cases involving Immutep Limited operate on a contingency basis, meaning there are no upfront costs unless there is a recovery.
- Will I need to appear in court for the Immutep Limited lawsuit?
In most cases, investors do not need to appear in court. The legal team manages the Immutep Limited case on behalf of participants.
- What documents are required for the Immutep Limited lawsuit?
To participate in the Immutep Limited lawsuit, investors may need to provide transaction records, purchase dates, number of shares, and loss details.
- What happens after I submit my trade information for Immutep Limited?
After submission, your details for the Immutep Limited case will be reviewed, and you may be contacted regarding eligibility or next steps.
- Is this legal advice for the Immutep Limited lawsuit?
No, this page provides information about the Immutep Limited case and does not constitute legal advice or create an attorney-client relationship.
- Why should I act quickly on the Immutep Limited case?
The lead plaintiff deadline for the Immutep Limited lawsuit is July 6, 2026. If you are an investor, you may have the opportunity to seek appointment as lead plaintiff or remain an absent class member.
EXPLORE MORE CASES
Gemini Space Station, Inc.
GEMI
Gemini Space Station, Inc. [GEMI] Securities Class Action Lawsuit Update
Lead Plaintiff Deadline: May 15, 2026
Class Period: September 12, 2025 - February 17, 2026
Aldeyra Therapeutics, Inc.
ALDX
Aldeyra Therapeutics, Inc. [ALDX] Securities Class Action Lawsuit Update
Lead Plaintiff Deadline: May 29, 2026
Class Period: November 3, 2023 - March 16, 2026